Jon Congleton

Jon Congleton

President & CEO

Jon has over thirty years of pharmaceutical experience with an emphasis on strategic execution, general management, and commercialization. Jon was an initial member of the Teva team responsible for the launch of Copaxone. During his time at Teva he held commercial and general management roles; both in Canada and the United States. Jon then moved into corporate strategy roles focused on Teva’s branded business. Jon then moved to Nivalis, a start-up focused on cystic fibrosis, as CEO where he led a successful IPO and clinical development program. Jon has a Bachelor’s degree in Marketing from Kansas State University.